[1]
Shin, J.-W. et al. 2018. Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study. Acta Dermato-Venereologica. 99, 1 (Oct. 2018), 41–46. DOI:https://doi.org/10.2340/00015555-3057.